Participants 44 67 6
migraine in adolescents
Participants 170 224 6
efficacy of rizatriptan 5 mg in adolescent migraineurs
Participants 286 371 11
Patients aged 12 to 17 years received rizatriptan 5 mg (n = 149) or placebo (n = 147)
Participants 1806 1896 3
effective on some measures when used in adolescents for the treatment of a migraine attack
